BlossomHill Therapeutics, Inc.

BlossomHill Therapeutics, Inc. (BLSM) priced its initial public offering on Aug 7, 2026 at $16.00 per share, within its $15.00–$17.00 range, raising $150M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $490.3M. Latham & Watkins advised the underwriters.

Status

IPO

Ticker

BLSM

Exchange

Nasdaq Global Select

Priced

Aug 7, 2026

IPO price

$16.00

Price range

$15.00–$17.00

Raised

$150M

Market cap at IPO price

$490.3M

First filed

Jul 17, 2026

Underwriters' counsel

Latham & Watkins

Sector

Biotech & pharma

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.